Ramelteon



Indications and Reactions:

Role Indications Reactions
Primary
Insomnia 47.1%
Neuralgia 11.8%
Passive Smoking 11.8%
Sedation 11.8%
Bipolar I Disorder 5.9%
Post-traumatic Stress Disorder 5.9%
Somnolence 5.9%
Mental Status Changes 16.7%
Atelectasis 8.3%
Autoimmune Hepatitis 8.3%
Lung Neoplasm Malignant 8.3%
Marasmus 8.3%
Plasma Cell Myeloma 8.3%
Respiratory Arrest 8.3%
Sleep Disorder 8.3%
Stevens-johnson Syndrome 8.3%
Systemic Inflammatory Response Syndrome 8.3%
Urinary Tract Infection 8.3%
Secondary
Drug Use For Unknown Indication 43.5%
Product Used For Unknown Indication 13.7%
Colon Cancer Metastatic 12.2%
Suicide Attempt 10.7%
Insomnia 9.2%
Prophylaxis 4.6%
Ovarian Cancer 2.3%
Pain 2.3%
Sleep Disorder 1.5%
Respiratory Arrest 22.7%
Completed Suicide 13.6%
Poisoning 9.1%
Pyrexia 9.1%
Intentional Drug Misuse 6.8%
Cardio-respiratory Arrest 4.5%
Drug Toxicity 4.5%
Headache 4.5%
Shock 4.5%
Cyanosis 2.3%
Death 2.3%
Multiple Drug Overdose 2.3%
Multiple Drug Overdose Intentional 2.3%
No Adverse Event 2.3%
Orthostatic Hypotension 2.3%
Overdose 2.3%
Sleep Disorder 2.3%
Weight Increased 2.3%
Concomitant
Prophylaxis 31.6%
Ovarian Cancer Recurrent 7.8%
Abdominal Pain 6.6%
Colorectal Cancer 6.6%
Product Used For Unknown Indication 6.5%
Constipation 5.9%
Stomatitis 4.8%
Hypoproteinaemia 3.3%
Premedication 3.1%
Prophylaxis Of Nausea And Vomiting 2.9%
Drug Use For Unknown Indication 2.8%
Nausea 2.4%
Breast Cancer 2.3%
Cancer Pain 2.2%
Gastritis 2.2%
Immunosuppression 2.0%
Colon Cancer 1.9%
Insomnia 1.9%
Stem Cell Transplant 1.9%
Pyrexia 1.3%
Intestinal Obstruction 13.3%
Ovarian Cancer Recurrent 10.2%
Febrile Neutropenia 8.8%
Interstitial Lung Disease 8.8%
White Blood Cell Count Decreased 6.6%
Malaise 5.8%
Platelet Count Decreased 5.3%
C-reactive Protein Increased 4.4%
Pneumonia 4.4%
Stomatitis 4.4%
Decreased Appetite 3.5%
Renal Failure Acute 3.5%
Liver Disorder 3.1%
Pseudomembranous Colitis 3.1%
Nausea 2.7%
Neutrophil Count Decreased 2.7%
Renal Impairment 2.7%
Dermatitis Acneiform 2.2%
Hypocalcaemia 2.2%
Somnolence 2.2%